Calamos Advisors LLC decreased its stake in MetLife Inc. (NYSE:MET) by 0.1% during the second quarter, Holdings Channel reports. The fund owned 991,284 shares of the company’s stock after selling 668 shares during the period. Calamos Advisors LLC’s holdings in MetLife were worth $39,483,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of MET. Dubuque Bank & Trust Co. raised its position in MetLife by 19.4% in the first quarter. Dubuque Bank & Trust Co. now owns 91,581 shares of the company’s stock valued at $4,024,000 after buying an additional 14,893 shares during the last quarter. WASHINGTON TRUST Co raised its position in MetLife by 1.7% in the first quarter. WASHINGTON TRUST Co now owns 113,191 shares of the company’s stock valued at $4,973,000 after buying an additional 1,856 shares during the last quarter. Pacad Investment Ltd. raised its position in MetLife by 400.6% in the first quarter. Pacad Investment Ltd. now owns 58,070 shares of the company’s stock valued at $2,552,000 after buying an additional 46,470 shares during the last quarter. Brick & Kyle Associates raised its position in MetLife by 33.7% in the first quarter. Brick & Kyle Associates now owns 6,149 shares of the company’s stock valued at $270,000 after buying an additional 1,550 shares during the last quarter. Finally, Addenda Capital Inc. raised its stake in shares of MetLife by 1.9% in the first quarter. Addenda Capital Inc. now owns 25,596 shares of the company’s stock worth $946,000 after buying an additional 489 shares in the last quarter. 74.80% of the stock is owned by institutional investors.
MetLife Inc. (NYSE:MET) traded up 0.81% during trading on Tuesday, hitting $43.75. 5,914,029 shares of the stock traded hands. The company has a market cap of $48.08 billion, a P/E ratio of 11.50 and a beta of 1.87. MetLife Inc. has a 12 month low of $35.00 and a 12 month high of $52.45. The company’s 50 day moving average price is $42.41 and its 200 day moving average price is $43.02.
MetLife (NYSE:MET) last announced its earnings results on Wednesday, August 3rd. The company reported $0.83 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by $0.52. MetLife had a net margin of 6.49% and a return on equity of 6.18%. The firm had revenue of $17 billion for the quarter, compared to analysts’ expectations of $17.35 billion. During the same quarter last year, the business earned $1.56 earnings per share. The business’s revenue was down 2.3% compared to the same quarter last year. On average, equities research analysts anticipate that MetLife Inc. will post $4.65 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 13th. Investors of record on Monday, August 8th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.66%. The ex-dividend date was Thursday, August 4th. MetLife’s dividend payout ratio (DPR) is 42.11%.
A number of analysts have recently issued reports on the stock. Evercore ISI assumed coverage on shares of MetLife in a research note on Wednesday, July 6th. They set a “buy” rating and a $52.00 target price for the company. Citigroup Inc. lowered their target price on shares of MetLife from $46.00 to $42.00 and set a “neutral” rating for the company in a research note on Thursday, July 7th. Zacks Investment Research raised shares of MetLife from a “sell” rating to a “hold” rating in a research note on Wednesday, June 22nd. Argus reissued a “buy” rating and set a $54.00 target price on shares of MetLife in a research note on Wednesday, September 7th. Finally, JPMorgan Chase & Co. reissued a “buy” rating and set a $51.00 target price on shares of MetLife in a research note on Wednesday, July 6th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. MetLife has a consensus rating of “Buy” and a consensus target price of $52.45.
In related news, EVP Maria R. Morris sold 2,000 shares of the firm’s stock in a transaction dated Friday, July 1st. The stock was sold at an average price of $39.43, for a total transaction of $78,860.00. Following the completion of the transaction, the executive vice president now directly owns 109,273 shares in the company, valued at approximately $4,308,634.39. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.27% of the company’s stock.
MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife Inc. (NYSE:MET).
Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.